Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
cmv-specific t-cells (1 trial)
nicotine (nicorette) (1 trial)
tobacco (1 trial)
Cytomegalovirus Infections (Phase 3)
Trials (2 total)
Trial APIs (3 total)